January 7, 2025 11:30 AM EST
Deals
Pharma
Manufacturing

BWX Tech­nolo­gies to buy Cana­di­an iso­tope mak­er for $525M

Anna Brown

News Reporter

This year’s first ra­dio­phar­ma­ceu­ti­cal deal is slat­ed to ex­pand BWX Tech­nolo­gies’ pres­ence in the North Amer­i­can nu­clear tech mar­ket as de­mand is ex­pect­ed to creep …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Gala­pa­gos to split in­to two com­pa­nies, slash head­count as it eyes turn­around

Maze files for first biotech IPO of 2025, fol­low­ing $115M fund­ing boost

No­vo ex­pands pact with Flag­ship's Va­lo to in­clude obe­si­ty, di­a­betes for $190M near-term

With schiz­o­phre­nia tri­al suc­cess, LB Phar­ma­ceu­ti­cals thinks about Phase 3 and next fund­ing

FDA sets an ef­fi­ca­cy thresh­old for fu­ture weight loss drugs

Every FDA drug ap­proval from 2024: Few­er nods, but long-await­ed treat­ments cross the fin­ish line

A service from the Financial Times